Myelodysplastic Syndrome (MDS) Clinical Trials

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED
N
Recruiting
  • Severe Aplastic Anemia
  • +2 more
  • Omidubicel (formerly NiCord (Registered Trademark) and CordIn (TM))
  • Bethesda, Maryland
    National Institutes of Health Clinical Center
2022-04-07
Apr 7, 2022
N
Recruiting
  • Aplastic Anemia
  • +3 more
  • Cord Blood Units
  • Bethesda, Maryland
    National Institutes of Health Clinical Center, 9000 Rockville Pi
2022-04-07
Apr 7, 2022
N
Enrolling by invitation
  • Acute Lymphoblastic Leukemia
  • +4 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2022-04-07
    Apr 7, 2022
    N
    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • Houston, Texas
    • +12 more
    2022-03-29
    Mar 29, 2022
    N
    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • Chandler, Arizona
    • +17 more
    2022-03-23
    Mar 23, 2022
    C
    Recruiting
    • Myelofibrosis
    • +13 more
    • Phoenix, Arizona
    • +54 more
    2022-03-04
    Mar 4, 2022
    M
    Active, not recruiting
    • Acute Myelogenous Leukemia (AML)
    • Myelodysplastic Syndrome (MDS)
    • Minneapolis, Minnesota
      Masonic Cancer Center at University of Minnesota
    2022-02-25
    Feb 25, 2022
    E
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +3 more
    • Duarte, California
    • +35 more
    2022-02-15
    Feb 15, 2022
    S
    Recruiting
    • Acute Lymphoblastic Leukemia (ALL)
    • +6 more
    • Anti-thymocyte globulin (rabbit)
    • +12 more
    • Memphis, Tennessee
      St. Jude Children's Research Hospital
    2022-01-31
    Jan 31, 2022
    G
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Durham, North Carolina
      Duke University Health System
    2022-01-10
    Jan 10, 2022
    J
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +4 more
    • Boston, Massachusetts
      Dana-Farber Cancer Institute
    2022-01-21
    Jan 21, 2022
    H
    Terminated
    • Myelodysplastic Syndrome (MDS)
    • Thrombocytopenia
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2022-01-20
    Jan 20, 2022
    R
    Recruiting
    • Acute Myeloid Leukemia (AML)
    • +2 more
    • Reduced-Intensity Conditioning Regimen
    • Myeloablative Conditioning Regimen
    • Pittsburgh, Pennsylvania
      UPMC Children's Hospital of Pittsburgh
    2022-01-05
    Jan 5, 2022
    A
    Completed
    • Myelodysplastic Syndrome (MDS)
    • AMV564 14-Day CIV
    • Duarte, California
    • +4 more
    2021-10-11
    Oct 11, 2021
    N
    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • +3 more
    • Cord Blood Transplant
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-09-22
    Sep 22, 2021
    G
    Completed
    • Acute Lymphoblastic Leukemia (ALL)
    • +4 more
    • Maywood, Illinois
    • +1 more
    2021-08-01
    Aug 1, 2021
    F
    Withdrawn
    • Myelodysplastic Syndrome (MDS)
    • (no location specified)
    2021-07-20
    Jul 20, 2021
    N
    Completed
    • Myelodysplastic Syndrome (MDS)
    • +2 more
    • WT1:126-134
    • +3 more
    • Bethesda, Maryland
      National Institutes of Health Clinical Center, 9000 Rockville Pi
    2021-06-15
    Jun 15, 2021
    H
    Completed
    • Myelodysplastic Syndrome (MDS)
    • Chronic Myelomonocytic Leukemia (CMML)
    • Tampa, Florida
      H. Lee Moffitt Cancer Center and Research Institute
    2021-06-10
    Jun 10, 2021
    C
    Recruiting
    • Fanconi Anemia
    • +3 more
    • New York, New York
    • +2 more
    2021-05-04
    May 4, 2021
    C
    Recruiting
    • Myelodysplastic Syndrome (MDS)
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer institute, Case Comprehensive Ca
    2021-04-21
    Apr 21, 2021
    M
    Completed
    • Fanconi Anemia
    • +2 more
    • New York, New York
    • +2 more
    2021-04-14
    Apr 14, 2021